Skip to content
10-K

Annual Report

CalciMedica, Inc. CALC

0001193125-26-088147

← back to feed
Filed
Mar 3, 2026 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding FY 2025 · Feb 26, 2026 15.74M sh
Shares Diluted FY 2025 · Dec 31, 2025 15.01M sh
Shares Diluted FY 2025 · Dec 31, 2024 11.25M sh
Capex FY 2025 · Dec 31, 2025 $28K
Capex FY 2025 · Dec 31, 2024 $8K
Operating Cash Flow FY 2025 · Dec 31, 2025 −$21.18M
Operating Cash Flow FY 2025 · Dec 31, 2024 −$21.15M
Short Term Investments FY 2025 · Dec 31, 2025 $1.5M
Short Term Investments FY 2025 · Dec 31, 2024 $10.73M
Cash And Equivalents FY 2025 · Dec 31, 2025 $11.52M
Cash And Equivalents FY 2025 · Dec 31, 2024 $7.94M
Stockholders Equity FY 2025 · Dec 31, 2025 −$6.64M
Stockholders Equity FY 2025 · Dec 31, 2024 $14.41M
Stockholders Equity FY 2025 · Dec 31, 2023 $8.16M
Current Liabilities FY 2025 · Dec 31, 2025 $3.78M
Current Liabilities FY 2025 · Dec 31, 2024 $3.68M
Total Liabilities FY 2025 · Dec 31, 2025 $20.23M
Total Liabilities FY 2025 · Dec 31, 2024 $5.38M
Current Assets FY 2025 · Dec 31, 2025 $13.53M
Current Assets FY 2025 · Dec 31, 2024 $19.67M
Total Assets FY 2025 · Dec 31, 2025 $13.59M
Total Assets FY 2025 · Dec 31, 2024 $19.79M
Eps Diluted FY 2025 · Dec 31, 2025 −$1.97
Eps Diluted FY 2025 · Dec 31, 2024 −$1.22
Eps Basic FY 2025 · Dec 31, 2025 −$1.97
Eps Basic FY 2025 · Dec 31, 2024 −$1.22
Sga Expense FY 2025 · Dec 31, 2025 $7.89M
Sga Expense FY 2025 · Dec 31, 2024 $9.73M
Rd Expense FY 2025 · Dec 31, 2025 $15.23M
Rd Expense FY 2025 · Dec 31, 2024 $14.48M
Net Income FY 2025 · Dec 31, 2025 −$29.56M
Net Income FY 2025 · Dec 31, 2024 −$13.7M
Operating Income FY 2025 · Dec 31, 2025 −$23.12M
Operating Income FY 2025 · Dec 31, 2024 −$24.2M